Over 2 years, the National Quality Forum (NQF) studied how to best incorporate social risk factors into healthcare measurements and identified the biggest challenges, said Shantanu Agrawal, MD, MPhil, CEO and president of NQF.
Transcript (slightly modified)
What has the National Quality Forum found regarding how to incorporate social risk factors into healthcare performance measures?
We conducted, initially, a trial for 2 years looking at just that question of how to include social risk factors in measurement. We really challenged clinicians and measure developers when they felt there was a reasonable basis for including social risk factors to actually find the data and include those in the risk models to see what kind of statistical impact the social risk factors had on the risk models themselves.
I think what it showed is that, number 1, this is a really challenging area, and more work clearly needs to be done, but 2, we did actually identify, collectively, a number of measures that could be endorsed with social risk factor adjustment built in. Really it was a very worthwhile exercise, scientifically, because oftentimes we actually did get there. Third, and I think the biggest challenge, is that the trial made clear that there are not a lot of great data sources for social risk factor adjustment—data sources that you can rely on to tell you on a patient level or on a population level what social risks factors are, what their prevalence is in various populations. Then, to really test that against the risk adjustment models for measurement.
So, as we look forward, we conducted this initial trial for 2 years, we are really looking to continue our work for the next 3 years at least to see if we can help surface better data sources, help bring more consistency to how clinicians and measure developers are thinking about this in the context of measurement, and hopefully continue to drive progress.
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
BCI Shows Promise of Personalized Endocrine Therapy in Breast Cancer
January 15th 2025The Breast Cancer Index (BCI) may help identify patients with low-risk breast cancer who could potentially benefit from reduced endocrine therapy, leading to improved quality of life and potentially lower health care costs.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Patient-Reported QOL Outcomes of Initial CLL Treatments: ASH 2024
January 8th 2025Quality-of-life (QOL) outcomes vary widely for patients receiving first-line treatment for chronic lymphocytic leukemia (CLL), according to research presented at the 2024 American Society of Hematology (ASH) meeting.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
BCI Shows Promise of Personalized Endocrine Therapy in Breast Cancer
January 15th 2025The Breast Cancer Index (BCI) may help identify patients with low-risk breast cancer who could potentially benefit from reduced endocrine therapy, leading to improved quality of life and potentially lower health care costs.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Patient-Reported QOL Outcomes of Initial CLL Treatments: ASH 2024
January 8th 2025Quality-of-life (QOL) outcomes vary widely for patients receiving first-line treatment for chronic lymphocytic leukemia (CLL), according to research presented at the 2024 American Society of Hematology (ASH) meeting.
Read More
2 Commerce Drive
Cranbury, NJ 08512